Day: March 24, 2021

Up to $25 million of funding at $75 million pre-money valuation to be available to the combined company concurrently with the merger  Cellect shareholders to retain 25% of the combined Company pre-funding Tel Aviv, Israel and Ashburn, VA , March 24, 2021 (GLOBE NEWSWIRE) — Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology that enables the functional selection of stem cells, and Quoin Pharmaceuticals Inc. (“Quoin”), a privately held specialty pharmaceutical company, today announced that the Boards of Directors of the two companies have unanimously approved a definitive Merger Agreement (the “Agreement”). Under the terms of the Agreement, Cellect shareholders will retain approximately 25% of the combined shares before investment while the shareholders of Quoin will receive shares of Cellect common stock...

DENVER, March 24, 2021 (GLOBE NEWSWIRE) — Vista Gold Corp. (NYSE American and TSX: VGZ) (“Vista” or the “Company”) today announced the positive results of hole VB21-002 at its Mt Todd Gold Project (“Mt Todd” or the “Project”) in the Northern Territory, Australia. This 459-meter drill hole intersected mineralization on-trend with the Batman deposit, 500 meters north-northeast in an area with no deep drilling and encountered a 30-meter intercept grading 1.23 g/t Au. The results of this hole demonstrate the strong potential for continuity of gold mineralization along the 5.4 km strike length of the Batman-Driffield Structural Trend located on Vista’s mineral licenses (“MLs”). As a result, the Company today announced that it is expanding its drilling program to include an additional 10 holes to focus deep drilling along the 1.0 km strike...

SOUTH SAN FRANCISCO, Calif., March 24, 2021 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced the appointment of Alan Colowick, M.D., to its board of directors. Dr. Colowick is an experienced biotech leader and has served in numerous executive and board roles. “We are thrilled to welcome Dr. Colowick as the newest member of the Harpoon Board of Directors,” said Ron Hunt, Chairman of the Board of Directors of Harpoon Therapeutics. “Alan is an accomplished industry leader who has managed and served on the boards of numerous innovative life science companies and he brings extensive experience and knowledge at this pivotal period of growth for Harpoon.” “I am delighted to join Harpoon’s Board of Directors during this important...

MONTERREY, Mexico, March 24, 2021 (GLOBE NEWSWIRE) — Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA” or “the Company”) (NYSE: FMX; BMV: FEMSAUBD) held its Annual Ordinary General Shareholders Meeting today, during which its shareholders approved among other things, the consolidated financial statements for the year ended December 31, 2020, the annual report presented by the Board of Directors, the declaration and payment of dividends corresponding to the fiscal year 2020 and the appointment or reelection of the members of the Board of Directors, the Audit Committee, the Corporate Practices Committee and the Strategy and Finance Committee of the Board for 2021. The shareholders’ meeting approved the payment of a cash dividend of Ps. 0.4792 per each Series “D” share and Ps. 0.3833 per each Series “B” share,...

MONTERREY, México, March 24, 2021 (GLOBE NEWSWIRE) — Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA” o “la Compañía”) (NYSE: FMX; BMV: FEMSAUBD) celebró el día de hoy su Asamblea General Ordinaria Anual, en la cual los accionistas aprobaron, entre otros asuntos, los estados financieros consolidados de la Compañía para el ejercicio fiscal terminado el 31 de diciembre de 2020, el informe anual presentado por el Consejo de Administración, la declaración y pago de un dividendo correspondiente al ejercicio 2020 y el nombramiento o reelección de los miembros del Consejo de Administración, de los Comités de Auditoría, de Prácticas Societarias y de Estrategia y Finanzas del Consejo de Administración para el año 2021. La asamblea de accionistas aprobó el pago de un dividendo en efectivo a razón de Ps. 0.4792 por cada acción Serie “D”...

To Nasdaq OMX Copenhagen24 March 2021Company announcement no. 07/2021 The BANK of Greenland Articles of Association Enclosed please find The BANK of Greenlands Articles of Association of 24 March 2021 Attachment07.Vedtægter_24032021_ENG

Til Nasdaq OMX Copenhagen24. marts 2021Selskabsmeddelelse nr. 07/2021 Vedtægter for GrønlandsBANKEN A/S Vedlagt følger vedtægter for GrønlandsBANKEN A/S af 24. marts 2021 Kontakt: Anni Søe Svendsen, telefon +299 34 78 02 – e-mail: aktionaer@banken.gl Vedhæftet fil07.Vedtægter_24032021_DK

LAVAL, Québec, March 24, 2021 (GLOBE NEWSWIRE) — Savaria Corporation (“Savaria”) (TSX: SIS), a global leader in the accessibility industry, is pleased to announce today its results for fiscal 2020. Highlights of the year 2020Revenue for the year was $354.5M, down $19.8M or 5.3%; Gross profit was $122.1M, down $3.2M or 2.5%, representing 34.5% of revenue compared to 33.5% in 2019; Adjusted net earnings were $28.5M, or $0.56 per share on a diluted basis; up $1.8M or 6.5%; Adjusted EBITDA was $59.8M, up $4.2M or 7.5%. in thousands of dollars, except per-share amounts and percentages Q4 YTD  2020     2019   Change   2020     2019   ChangeRevenue $ 90,601   $ 96,437   (6.1 )% $ 354,496   $ 374,340   (5.3 )%Gross profit $ 30,131   $ 34,083   (11.6 )% $ 122,125   $ 125,311   (2.5 )%% of revenue   33.3 %   35.3 % n/a    34.5 %   33.5 % n/a Adjusted...

LAVAL, Québec, 24 mars 2021 (GLOBE NEWSWIRE) — Savaria Corporation (« Savaria ») (TSX : SIS), un chef de file mondial de l’industrie de l’accessibilité, divulgue aujourd’hui les résultats de son exercice 2020. Faits saillants de l’année 2020Revenus de 354,5 M $, en baisse de 19,8 M $ ou 5,3 %; Marge brute de 122,1 M $, en baisse de 3,2 M $ ou 2,5 %, représentant 34,5 % des revenus comparativement à 33,5 % en 2019; Résultat net ajusté de 28,5 M $, ou 0,56 $ par action sur une base diluée; en hausse de 1,8 M $ ou 6,5 %; BAIIA ajusté de 59,8 M $, en hausse de 4,2 M $ ou 7,5 %. en milliers de dollars, sauf les montants par action et les pourcentages T4 Cumul annuel  2020     2019   Variation   2020     2019   VariationRevenus   90,601 $   96,437 $ (6.1 )%   354,496 $   374,340 $ (5.3 )%Marge brute   30,131 $   34,083 $ (11.6 )%   122,125 $   125,311 $ (2.5 )%%...